Transforming Care for Individuals with Childhood-onset Systemic Lupus Erythematosus

Description

This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSLE when integrated into medical care. This TEACH program aims to teach participants skills in order to cope with fatigue, pain, and depressive symptoms--symptoms that commonly affect adolescents and young adults with lupus.

Conditions

Systemic Lupus Erythematosus of Childhood (Disorder)

Talk to us

Study Overview

On this page

Study Details

Study overview

This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSLE when integrated into medical care. This TEACH program aims to teach participants skills in order to cope with fatigue, pain, and depressive symptoms--symptoms that commonly affect adolescents and young adults with lupus.

Transforming Behavioral Healthcare to Improve the Quality of Life for Individuals with Childhood-onset Lupus

Transforming Care for Individuals with Childhood-onset Systemic Lupus Erythematosus

Condition
Systemic Lupus Erythematosus of Childhood (Disorder)
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama Birmingham Hospital, Birmingham, Alabama, United States, 35233

New Orleans

Children's Hospital of New Orleans/ Tulane University, New Orleans, Louisiana, United States, 70118

Grand Rapids

Helen Devos Children's Hospital, Grand Rapids, Michigan, United States, 49503

Bronx

Montefiore Medical Center, Bronx, New York, United States, 10467

Cincinnati

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States, 45229

Seattle

Seattle Children's Hospital, Seattle, Washington, United States, 98105

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 1) be diagnosed with cSLE, meeting the revised American College of Rheumatology Classification Criteria for SLE by age 18 years
  • * 2) be between the ages of 12 and 22 years
  • * 3) in recognition of the heterogeneity of cSLE symptoms, have elevations in fatigue (i.e., T scores ≥60; or at least moderate symptoms, on the PROMIS measure) OR depressive symptoms (i.e., ≥10 on the PHQ-9), OR pain (i.e., average pain ≥3 out of 10 on the Pain VAS)
  • * 4) have English language proficiency (their primary caregiver can have English or Spanish language proficiency for the child to enroll)
  • * 5) those under age 18 years (US), or 16 years (Canada) must have a consenting caregiver
  • * 1) other chronic medical conditions (e.g., juvenile arthritis)
  • * 2) a documented developmental delay, severe cognitive impairment, or thought disorder
  • * 3) an untreated major psychiatric illness (e.g., bipolar disorder, psychosis, severe depression (score ≥20) or active suicidal ideation (SI), based on the Pediatric Health Questionnaire (PHQ-9) items plus clinical interview; see Measures section)

Ages Eligible for Study

12 Years to 22 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Michigan State University,

Natoshia R Cunningham, PhD, PRINCIPAL_INVESTIGATOR, Michigan State University

Andrea Knight, MD, MSCE, PRINCIPAL_INVESTIGATOR, The Hospital for Sick Children

Study Record Dates

2027-09-30